Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?

Researchers based in India have demonstrated that horses inoculated with an inactivated dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are able to produce large amounts of strong antibodies that can neutralize multiple variants

Study: Development of Equine Immunoglobulin Fragment F(ab’)2 with High Neutralizing Capability against SARS-CoV-2. Image Credit: ktsdesign / Shutterstock

A pre-print version of the research paper is available to read in full on the bioRxiv*server.

No time for horsing around

The ongoing coronavirus disease 2019 (COVID-19) pandemic has given rise to a number of vaccines now in circulation globally. The rate of deployment of these vaccines, however, is severely lagging behind the rate of the virus’s spread and mutation.

The team of researchers has thus been investigating an alternative solution: antibodies from large mammals.

Large animals, like horses, are able to produce antibodies in high quantities that can then be reapplied and used in human subjects, rather than having to synthesize such proteins from scratch.

Harshan and collaborators inoculated several horses with inactivated Indian SARS-CoV-2 cultures mixed with Freund’s Complete Adjuvant – a solution that promotes cell-mediated immunity. Plasma samples were taken from the immunized horses and then tested for antibody response. The researchers found that the extracted antibodies were effective at neutralizing both the ancestral and deviant strains of COVID-19. This news is especially promising as the antibodies can be sourced from the horses after less than two months from initial inoculation with the inactivated virus and can be sourced in large quantities.

Additionally, the antibodies can penetrate deeper into organs and tissues due to their smaller size and lesser cellular affinity, only adding to their already beneficial properties.

This research comes out after a series of trials already conducted on the applicability of horse antibodies to SARS-CoV-2. It further highlights the easy and inexpensive accessibility of these types of immunization programs.

Alternative methods

Antibody immunity provided by large animals is just one of many new arising methods for tackling the COVID-19 pandemic. The virus is still spreading at a rate faster than vaccines can be dispensed, and scientists currently estimate it may take several years to be able to get the virus fully under control.

Worldwide, coronavirus cases now breach over 119 million, and as such, the roll-out of effective alternate therapeutics and prophylactics will likely become vital for global society to surmount the pandemic.

*Important Notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Michael Burgess

Written by

Michael Burgess

Michael graduated with a first-class degree in Zoology from the University of Hull, and later received a Masters degree in Palaeobiology from the University of Bristol.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Burgess, Michael. (2021, March 12). Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?. News-Medical. Retrieved on August 10, 2022 from

  • MLA

    Burgess, Michael. "Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?". News-Medical. 10 August 2022. <>.

  • Chicago

    Burgess, Michael. "Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?". News-Medical. (accessed August 10, 2022).

  • Harvard

    Burgess, Michael. 2021. Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?. News-Medical, viewed 10 August 2022,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Disease progression in the rhesus macaque model upon inoculation with the Delta, Omicron BA.1, and Omicron BA.2 variants